Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics, Inc. (LENZ) Shares Outstanding (Weighted Average) (2022 - 2023)

LENZ Therapeutics (LENZ) has disclosed Shares Outstanding (Weighted Average) for 2 consecutive years, with $2.0 million as the latest value for Q3 2023.

  • On a quarterly basis, Shares Outstanding (Weighted Average) fell 96.41% to $2.0 million in Q3 2023 year-over-year; TTM through Sep 2023 was $2.0 million, a 96.41% decrease, with the full-year FY2022 number at $54.9 million, changed N/A from a year prior.
  • Shares Outstanding (Weighted Average) was $2.0 million for Q3 2023 at LENZ Therapeutics, roughly flat from $2.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $54.9 million in Q4 2022 to a low of $2.0 million in Q1 2023.